27 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
into the final dosage form for incorporation into STS101 packaging, sterilization, physical and regulatory labeling and other finishing activities
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
(chemistry, manufacturing and controls), formulating active pharmaceutical ingredients into the final dosage form for incorporation into STS101 packaging … the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale
8-K
EX-10.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
), formulating active pharmaceutical ingredients into the final dosage form for incorporation into STS101 packaging, sterilization, physical and regulatory
8-K
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
device components (Satsuma owns commercial mold tooling) Filling, assembly and packaging. (Satsuma owns custom, high-speed, automated manufacturing
8-K
EX-1.1
ac7sopc
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
S-3
EX-1.2
91cgnxeoyc6 5315zo
23 Oct 20
Shelf registration
4:48pm
10-K
kxb6dd6o
10 Mar 20
Annual report
4:20pm
10-Q
pwirxanawqy0fo7 cn20
12 Nov 19
Quarterly report
4:31pm
424B4
mj5p7qp0k1d5i 218e
13 Sep 19
Prospectus supplement with pricing info
5:08pm